Keywords: Dr Reddy's. Oceana Thera, Deflux, India
Dr Reddy’s gains Indian rights to Oceana’s Deflux
Article | 18 May 2011
Privately-held US company Oceana Therapeutics, which is focused on acquiring, developing and commercializing best-in-class specialty therapeutics, has entered into a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
